A Comprehensive Review of Spinal Cord Stimulator Infections

Curr Pain Headache Rep. 2022 Dec;26(12):877-882. doi: 10.1007/s11916-022-01090-2. Epub 2022 Dec 1.

Abstract

Spinal cord stimulator (SCS) is approved to treat various pain conditions and is commonly seen in the chronic pain patient population. Due to the nature of the device and its location, infections associated with SCS have a particularly high morbidity. According to post-market data and medical device reports, 87% of patients receiving SCS implants were given perioperative antibiotics as the implantable neurostimulator or receiver pocket serve as the most common sites of infection. The most common antibiotics for surgical prophylaxis given are first-generation cephalosporins (cefalexin, cefazolin) at the time of implantation. If deep infection is suspected, imaging in the form of CT scan should be obtained as physical exam is not always sufficient. For infections involving the epidural space, vertebra, or intervertebral discs, MRI is the preferred imaging modality. If meningitis is suspected, a lumbar puncture is recommended. Positive cultures can help guide antibiotic therapy.

Keywords: Antibiotic therapy; Chronic pain; Infection; Neuromodulation; Spinal cord stimulation.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Chronic Pain* / therapy
  • Humans
  • Retrospective Studies
  • Spinal Cord
  • Spinal Cord Stimulation* / methods
  • Spine

Substances

  • Anti-Bacterial Agents